UCH-L1 and GFAP serum levels in neonates with hypoxic-ischemic encephalopathy: A single center pilot study

Frontiers in Neurology

Volumn 5, Issue DEC, 2014, Pages

  Douglas Escobar, Martha V ^a,b   Heaton, Shelley C ^c   Bennett, Jeffrey ^a   Young, Linda J ^d   Glushakova, Olena ^e   Xu, Xiaohui ^c   Barbeau, Daphna Yasova ^a   Rossignol, Candice ^a   Miller, Cindy ^a   Crow, Alissa M Old ^a   Hayes, Ronald L ^e   Weiss, Michael D ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d Department of Radiology University of Florida ^*  (United States)

^e BANYAN BIOMARKERS INC   (United States)

Author keywords

Biomarkers; GFAP; HIE; UCH L1

Indexed keywords

BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; UBIQUITIN C TERMINAL HYDROLASE L1; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG;

ARTICLE; BASAL GANGLION; BAYLEY SCALES OF INFANT DEVELOPMENT; BRAIN DAMAGE; CLINICAL ARTICLE; COGNITIVE DEVELOPMENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; CORRELATIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MOTOR DEVELOPMENT; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; UMBILICAL CORD BLOOD; WHITE MATTER INJURY;

EID: 84920995891     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00273     Document Type: Article

References (43)

1. Vannucci R. Hypoxia ischemia: pathogenesis and neuropathology. In: Fanaroff A, editor. Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant. 6th ed. St. Louis, MO: Mosby (1997). p. 856-91.
2. Giffard RG, Monyer H, Choi DW. Selective vulnerability of cultured cortical glia to injury by extracellular acidosis. Brain Res (1990) 530(1):138-41. doi: 10.1016/0006-8993(90)90670-7
3. Low JA, Lindsay BG, Derrick EJ. Threshold of metabolic acidosis associated with newborn complications. Am J Obstet Gynecol (1997) 177(6):1391-4. doi:10.1016/S0002-9378(97)70080-2
4. MacDonald HM, Mulligan JC, Allen AC, Taylor PM. Neonatal asphyxia. I. Relationship of obstetric and neonatal complications to neonatal mortality in 38,405 consecutive deliveries. J Pediatr (1980) 96(5):898-902. doi:10.1016/S0022-3476(80)80574-9
5. Finer NN, Robertson CM, Richards RT, Pinnell LE, Peters KL. Hypoxic-ischemic encephalopathy in term neonates: perinatal factors and outcome. J Pediatr (1981) 98(1):112-7. doi:10.1016/S0022-3476(81)80555-0
6. Robertson CM, Finer NN, Grace MG. School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term. J Pediatr (1989) 114(5):753-60. doi:10.1016/S0022-3476(89)80132-5
7. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol (1976) 33(10):696-705. doi:10.1001/archneur.1976.00500100030012
8. Wyatt JS, Gluckman PD, Liu PY, Azzopardi D, Ballard R, Edwards AD, et al. Determinants of outcomes after head cooling for neonatal encephalopathy. Pediatrics (2007) 119(5):912-21. doi:10.1542/peds.2006-2839
9. Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med (2009) 361(14):1349-58. doi:10.1056/NEJMoa0900854
10. Tagin MA, Woolcott CG, Vincer MJ, Whyte RK, Stinson DA. Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis. Arch Pediatr Adolesc Med (2012) 166(6):558-66. doi:10.1001/archpediatrics.2011.1772
11. Garfinkle J, Sant'Anna GM, Wintermark P, Ali N, Morneault L, Koclas L, et al. Cooling in the real world: therapeutic hypothermia in hypoxic-ischemic encephalopathy. Eur J Paediatr Neurol (2013) 17(5):492-7. doi:10.1016/j.ejpn.2013.03.006
12. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med (2005) 353(15):1574-84. doi:10.1056/NEJMcps050929
13. Leijser LM, Vein AA, Liauw L, Strauss T, Veen S, Wezel-Meijler Gv. Prediction of short-term neurological outcome in full-term neonates with hypoxic-ischaemic encephalopathy based on combined use of electroencephalogram and neuro-imaging. Neuropediatrics (2007) 38(5):219-27. doi:10.1055/s-2007-992815
14. Jouvet P, Cowan FM, Cox P, Lazda E, Rutherford MA, Wigglesworth J, et al. Reproducibility and accuracy of MR imaging of the brain after severe birth asphyxia. AJNR Am J Neuroradiol (1999) 20(7):1343-8.
15. Boichot C, Walker PM, Durand C, Grimaldi M, Chapuis S, Gouyon JB, et al. Term neonate prognoses after perinatal asphyxia: contributions of MR imaging, MR spectroscopy, relaxation times, and apparent diffusion coefficients. Radiology (2006) 239(3):839-48. doi:10.1148/radiol.2393050027
16. van Laerhoven H, de Haan TR, Offringa M, Post B, van der Lee JH. Prognostic tests in term neonates with hypoxic-ischemic encephalopathy: a systematic review. Pediatrics (2012) 131(1):88-98. doi:10.1542/peds.2012-1297
17. Bonifacio SL, Glass HC, Peloquin S, Ferriero DM. A new neurological focus in neonatal intensive care. Nat Rev Neurol (2011) 7(9):485-94. doi:10.1038/nrneurol.2011.119
18. Gunn AJ, Wyatt JS, Whitelaw A, Barks J, Azzopardi D, Ballard R, et al. Therapeutic hypothermia changes the prognostic value of clinical evaluation of neonatal encephalopathy. J Pediatr (2008) 152(1):55-8. doi:10.1016/j.jpeds.2007.06.003
19. Thoresen M, Hellström-Westas L, Liu X, de Vries LS. Effect of hypothermia on amplitude-integrated electroencephalogram in infants with asphyxia. Pediatrics (2010) 126(1):e131-9. doi:10.1542/peds.2009-2938
20. Eng LF. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol (1985) 8(4-6):203-14. doi:10.1016/S0165-5728(85)80063-1
21. Day IN, Thompson RJ. UCHL1 (PGP 9.5): neuronal biomarker and ubiquitin system protein. Prog Neurobiol (2009) 90(3):327-62. doi:10.1016/j.pneurobio.2009.10.020
22. Liu MC, Akinyi L, Scharf D, Mo J, Larner SF, Muller U, et al. Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats. Eur J Neurosci (2010) 31(4):722-32. doi:10.1111/j.1460-9568.2010.07097.x
23. Mondello S, Linnet A, Buki A, Robicsek S, Gabrielli A, Tepas J, et al. Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury. Neurosurgery (2011) 70(3):666-75. doi:10.1227/NEU.0b013e318236a809
24. Papa L, Akinyi L, Liu MC, Pineda JA, Tepas JJ III, Oli MW, et al. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit Care Med (2009) 38(1):138-44. doi:10.1097/CCM.0b013e3181b788ab
25. Papa L, Lewis LM, Falk JL, Zhang Z, Silvestri S, Giordano P, et al. Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann Emerg Med (2011) 59(6):471-83. doi:10.1016/j.annemergmed.2011.08.021
26. Papa L, Lewis LM, Silvestri S, Falk JL, Giordano P, Brophy GM, et al. Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J Trauma Acute Care Surg (2012) 72(5):1335-44. doi:10.1097/TA.0b013e3182491e3d
27. Czeiter E, Mondello S, Kovacs N, Sandor J, Gabrielli A, Schmid K, et al. Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. J Neurotrauma (2012) 29(9):1770-8. doi:10.1089/neu.2011.2127
28. Brophy GM, Mondello S, Papa L, Robicsek SA, Gabrielli A, Tepas J3rd, et al. Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. J Neurotrauma (2011) 28(6):861-70. doi:10.1089/neu.2010.1564
29. Ennen CS, Huisman TA, Savage WJ, Northington FJ, Jennings JM, Everett AD, et al. Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling. Am J Obstet Gynecol (2011) 205(3):e1-7. doi:10.1016/j.ajog.2011.06.025
30. Mondello S, Palmio J, Streeter J, Hayes RL, Peltola J, Jeromin A. Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizure. BMC Neurol (2012) 12(1):85. doi:10.1186/1471-2377-12-85
31. Diaz-Arrastia R, Wang KK, Papa L, Sorani MD, Yue JK, Puccio AM, et al. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 (UCH-L1) and glial fibrillary acidic protein (GFAP). J Neurotrauma (2014) 31(1):19-25. doi:10.1089/neu.2013.3040
32. Okonkwo DO, Yue JK, Puccio AM, Panczykowski DM, Inoue T, McMahon PJ, et al. GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study. J Neurotrauma (2013) 30(17):1490-7. doi:10.1089/neu.2013.2883
33. Zoltewicz JS, Scharf D, Yang B, Chawla A, Newsom KJ, Fang L. Characterization of antibodies that detect human GFAP after traumatic brain injury. Biomark Insights (2012) 7:71-9. doi:10.4137/BMI.S9873
34. Barkovich AJ, Hajnal BL, Vigneron D, Sola A, Partridge JC, Allen F, et al. Prediction of neuromotor outcome in perinatal asphyxia: evaluation of MR scoring systems. AJNR Am J Neuroradiol (1998) 19(1):143-9.
35. Bayley N. Bayley Scales of Infant and Toddler Development. 3rd ed. San Antonio, TX: Harcourt Assessment (2006).
36. Thompson RJ, Doran JF, Jackson P, Dhillon AP, Rode J. PGP 9.5 - a new marker for vertebrate neurons and neuroendocrine cells. Brain Res (1983) 278(1-2):224-8. doi:10.1016/0006-8993(83)90241-X
37. Lewis SB, Wolper RA, Miralia L, Yang C, Shaw G. Detection of phosphorylated NF-H in the cerebrospinal fluid and blood of aneurysmal subarachnoid hemorrhage patients. J Cereb Blood Flow Metab (2008) 28(6):1261-71. doi:10.1038/jcbfm.2008.12
38. Massaro AN, Jeromin A, Kadom N, Vezina G, Hayes RL, Wang KK, et al. Serum biomarkers of MRI brain injury in neonatal hypoxic ischemic encephalopathy treated with whole-body hypothermia: a pilot study. Pediatr Crit Care Med (2013) 14(3):310-7. doi:10.1097/PCC.0b013e3182720642
39. Blyth BJ, Farahvar A, He H, Nayak A, Yang C, Shaw G, et al. Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury. J Neurotrauma (2011) 28(12):2453-62. doi:10.1089/neu.2010.1653
40. Kumar A, Mittal R, Khanna HD, Basu S. Free radical injury and blood-brain barrier permeability in hypoxic-ischemic encephalopathy. Pediatrics (2008) 122(3):e722-7. doi:10.1542/peds.2008-0269
41. Douglas-Escobar M, Weiss MD. Biomarkers of brain injury in the premature infant. Front Neurol (2012) 3:185. doi:10.3389/fneur.2012.00185
42. Chalak LF, Sánchez PJ, Adams-Huet B, Laptook AR, Heyne RJ, Rosenfeld CR. Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy. J Pediatr (2014) 164(3):468-474e1. doi:10.1016/j.jpeds.2013.10.067
43. Douglas-Escobar M, Weiss MD. Biomarkers of hypoxic-ischemic encephalopathy in newborns. Front Neurol (2012) 3:144. doi:10.3389/fneur.2012.00144